标题
Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy
作者
关键词
-
出版物
Nature Communications
Volume 7, Issue -, Pages 11838
出版商
Springer Nature
发表日期
2016-06-20
DOI
10.1038/ncomms11838
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pegylated liposomal doxorubicin in the management of ovarian cancer
- (2014) Nicoletta Staropoli et al. CANCER BIOLOGY & THERAPY
- nab-paclitaxel for the management of patients with advanced non-small-cell lung cancer
- (2014) Vera Hirsh Expert Review of Anticancer Therapy
- Albumin-Bound Paclitaxel: The Benefit of This New Formulation in the Treatment of Various Cancers
- (2014) M. Montana et al. JOURNAL OF CHEMOTHERAPY
- State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
- (2014) Charlene M. Dawidczyk et al. JOURNAL OF CONTROLLED RELEASE
- Emerging applications for ferumoxytol as a contrast agent in MRI
- (2014) Mustafa R. Bashir et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Theranostic Nanoparticles
- (2014) F. Chen et al. JOURNAL OF NUCLEAR MEDICINE
- A Modular Labeling Strategy for In Vivo PET and Near-Infrared Fluorescence Imaging of Nanoparticle Tumor Targeting
- (2014) C. Perez-Medina et al. JOURNAL OF NUCLEAR MEDICINE
- Cancer nanomedicines: closing the translational gap
- (2014) Alberto Gabizon et al. LANCET
- Imaging and Nanomedicine in Inflammatory Atherosclerosis
- (2014) W. J. M. Mulder et al. Science Translational Medicine
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- Treatment innovations for metastatic breast cancer: Nanoparticle albumin-bound (NAB) technology targeted to tumors
- (2013) Ana Lluch et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cancer Nanomedicine: From Drug Delivery to Imaging
- (2013) E. K.-H. Chow et al. Science Translational Medicine
- Personalized Nanomedicine
- (2012) T. Lammers et al. CLINICAL CANCER RESEARCH
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Pegylated Liposomal Doxorubicin
- (2011) Sean T. Duggan et al. DRUGS
- Pharmacological basis of pegylated liposomal doxorubicin: Impact on cancer therapy
- (2011) Alberto Gabizon et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Quantitative CT Imaging of the Spatial and Temporal Distribution of Liposomes in a Rabbit Tumor Model
- (2009) Jinzi Zheng et al. MOLECULAR PHARMACEUTICS
- Standardized methods for the production of high specific-activity zirconium-89
- (2009) Jason P. Holland et al. NUCLEAR MEDICINE AND BIOLOGY
- Imaging in the era of molecular oncology
- (2008) Ralph Weissleder et al. NATURE
- Seven challenges for nanomedicine
- (2008) Wendy R. Sanhai et al. Nature Nanotechnology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started